Preparing Serine-Free Medium

A dropout medium is an experiment in ionic composition as much as in nutrient supply.

The Two Problems

ProblemMechanismConsequence
Substitution changes compositionRemoving an amino acid removes its mass and chargeOsmolarity falls; sodium or chloride may shift
Serum reintroduces the nutrientSerum contains serine and glycine at hundreds of micromolarMedium is not serine-free

Important distinction. A commercial "serine-free" formulation may exist, but most laboratories make the medium by omitting the amino acid from a custom powder or by using a dropout kit. In both cases the substitution used to maintain osmolarity must be stated, because an isosmotic replacement (typically glycine or sodium chloride) is itself a variable.

Part 1 — Making the Medium

StepDetailWhy
Base formulationCustom powder without serine, or a dropout kitConsistency between batches
Osmotic replacementEquimolar glycine, or NaCl, or sucroseDocument which, and use the same one throughout
Glycine decisionRemove together, or keepDetermines whether serine or glycine is limiting
SerumDialysed, or define the contributionSerum serine is not negligible
pHAdjust after additionsDropout media often drift
FiltrationSterile filter after complete dissolutionPrecipitation of divalent salts
VerificationLC-MS or a serine-responsive readoutConfirms what was made

The seventh step is the one that distinguishes a controlled experiment from an assumed one. A single LC-MS injection of the prepared medium, with a serine standard curve, takes an hour and settles the question of whether serine is present.

Part 2 — Serum and the Illusion of Deprivation

Serum fractionSerine contentMitigation
Undialysed FBSHundreds of micromolarNot compatible with deprivation
Dialysed FBS (10 kDa)Low but not zeroVerify by LC-MS
Serum-free, definedZero by formulationRequires a validated supplement
Low-serum (1–2%)Reduced but variableNot a substitute for dialysis

Caveat on dialysis. Dialysis removes small molecules, but the residual concentration depends on the membrane cut-off, the ratio of serum to buffer, and the number of exchanges. A "dialysed serum" that still contains 50 µM serine is adequate for some experiments and useless for a PHGDH dependency study. Measured, not assumed.

Part 3 — What the Experiment Can Support

ClaimRequiresNot sufficient
"Cells require serine synthesis"Serine-free, dialysed serum, PHGDH loss, serine rescueGrowth difference in standard medium
"Glycine is limiting"Serine-free but glycine-replete armsRemoving both
"One-carbon supply is limiting"Formate or nucleoside rescueSerine rescue alone
"The dependency is specific to serine"Glycine and formate arms without rescueA single dropout condition

Readout note. The rescue panel — serine, glycine, formate, nucleosides, and a methyl donor — is what converts a deprivation phenotype into a statement about which product was limiting. Without it, "serine dependency" means only that removing serine slowed growth.

Part 4 — Model Requirements and Recurring Failures

RequirementWhy
Osmotic replacement statedIt is a variable
Serum dialysis documented and verifiedOtherwise the medium is not free
Glycine handled deliberatelyIt is interconvertible with serine
Duration of deprivation matched to the readoutAdaptation occurs within a day
Proliferation measuredSerine demand follows biomass
Rescue panel includedIdentifies the limiting product

Recurring failures:

  • • Medium called serine-free without verification.
  • • Osmolarity not matched, so the phenotype is partly osmotic.
  • • Glycine removed at the same time, confounding the interpretation.
  • • Undialysed serum used, which supplies the amino acid.
  • • Deprivation too short or too long, capturing adaptation or death rather than dependency.
  • • No rescue panel, leaving the mechanism unassigned.
  • • Batch-to-batch variation in custom powder not documented.

Part 5 — A Practical Sequence

  1. Verify the base medium's serine and glycine content by LC-MS.
  2. Prepare the dropout medium with a stated osmotic replacement.
  3. Dialyse serum and verify the residual serine.
  4. Test growth over 72 hours with a serine dose–response (0, 10, 30, 100, 400 µM).
  5. In the serine-free condition, run the rescue panel.
  6. Only then introduce the genetic perturbation.

The fourth step is what makes the experiment quantitative: a dose–response identifies the concentration at which the dependency appears, which is more informative than a single zero-serine arm.

If you need dropout media with verified composition and osmolarity matching, we can scope the protocol with you.

Contact EDITGENE to request a project consultation or quote.

Scientific scope and validation note

Serum contribution, cellular serine synthesis capacity and adaptation times vary by cell type and formulation. Verification is required for each medium batch.

Growth in a dropout medium does not establish which nutrient was limiting, and a rescue with serine does not establish that serine synthesis was the required function.

Scientific interpretation and experimental design

  • • A dropout changes osmolarity. Replace and state it.
  • • Serum contains serine. Dialyse and verify.
  • • Glycine is not neutral. Decide deliberately.
  • • Verify the medium. One LC-MS run.
  • • Dose–response beats zero. It locates the threshold.
  • • Rescue panel assigns the mechanism.

Selected references for further reading

  • • Maddocks OD, et al. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature. 2013;493:542–546.
  • • Labuschagne CF, et al. Serine, but not glycine, supports one-carbon metabolism and proliferation of cancer cells. Cell Reports. 2014;7:1248–1258.
  • • Yang L, et al. Serine and one-carbon metabolism in cancer. Nature Reviews Cancer. 2016;16:650–662.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: